A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry

A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry

Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk crit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser: Boucly, A, Jais, X, Cottin, V, Savale, L, Prevot, G, O'Connell, C, Picard, F, Weatherald, J, Groote, P De, Jevnikar, M, Bergot, E, Chaouat, A, Chabanne, C, Bourdin, A, Rottat, L, Montani, D, Simonneau, G, Humbert, M, Sitbon, O
Format: Artikel
Sprache:eng
Schlagworte:
Multivariate analysis
Pulmonary hypertension
Risk assessment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk criteria achieved at the first follow-up visit: NYHA FC I or II, 6MWD > 440m, right atrial pressure (RAP) < 8 mmHg and cardiac index (CI) > 2.5 L/min/m2.
ISSN:1073-449X
1535-4970